Soma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Study of SOM0226 in Familial Amyloid Polyneuropathy
Condition:   Familial Amyloid Polyneuropathy (FAP)Intervention:   Drug: SOM0226Sponsors:   SOM Biotech SL;   Hospital Vall d'HebronRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2014 Category: Research Source Type: clinical trials

SOM 230 and Gemcitabine in Advanced Pancreatic Cancer
Condition:   Pancreatic CancerInterventions:   Drug: SOM 230 LAR;   Drug: GemcitabineSponsors:   H. Lee Moffitt Cancer Center and Research Institute;   Novartis PharmaceuticalsCompleted - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2011 Category: Research Source Type: clinical trials

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
Condition:   Ductal Carcinoma in SituIntervention:   Drug: SOM 230 / PasireotideSponsor:   New York University School of MedicineRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2011 Category: Research Source Type: clinical trials

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
Condition:   Ductal Carcinoma in SituIntervention:   Drug: SOM 230 / PasireotideSponsor:   New York University School of MedicineRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2011 Category: Research Source Type: clinical trials

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
Condition:   Ductal Carcinoma in SituIntervention:   Drug: SOM 230 / PasireotideSponsor:   New York University School of MedicineRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2011 Category: Research Source Type: clinical trials